Navigation Links
TeamStaff Renames Subsidiary to Reflect Expanding Government Services
Date:2/12/2008

with the U.S. Securities Exchange Commission. For a discussion of such risks and uncertainties which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report or Form 10-K for the most recently ended fiscal year. The information in this release should be considered accurate only as of the date of the release. TeamStaff expressly disclaims any current intention to update any forecasts, estimates or other forward-looking statements contained in this press release.

CONTACTS:

Rick Filippelli, President and CEO

TeamStaff, Inc.

1 Executive Drive

Somerset, NJ 08873

866-352-5304

Donald C. Weinberger/Alisa Steinberg (media)

Wolfe Axelrod Weinberger Associates, LLC

212-370-4500

don@wolfeaxelrod.com

alisa@wolfeaxelrod.com


'/>"/>
SOURCE TeamStaff, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. TeamStaff Receives A Letter of Reprimand From Nasdaq; No Further Action Contemplated
2. TeamStaff Receives Nasdaq Determination Letter
3. TeamStaff Reports Fourth Quarter and Fiscal 2007 Results; Posts Fourth Quarter Income From Operations
4. TeamStaff Sells Per Diem Business Unit
5. Bayer Corporation Renames Its U.S. Foundation, Refocuses Charitable Giving Areas
6. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
7. MedCom USAs Subsidiary Card Activation Technologies, Inc.s SB2 Registration Declared Effective by SEC
8. Carrington Subsidiary DelSite to Present at International Vaccine Conference in Ireland
9. MGT Capital Investments Announces New Commercial Partnerships for Subsidiary Company Medicexchange PLC
10. Natural Nutrition Subsidiary Reports Record Third Quarter Revenue and EBITDA
11. Cash Technologies Subsidiary Signs Services and Licensing Agreement With TriCap Health Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... and SUNNYVALE, Calif., Dec. 6 Pharmacyclics, ... results from a Phase I/II study showing safety ... recurrent non-Hodgkin,s Lymphoma (NHL) treated with its HDAC ... were presented today at the 51st ASH Annual ... # 2726). ,, PCI-24781 is an oral ...
(Date:12/6/2009)... Scientists in Cambridge have discovered that the loss of a ... This is the first study to show that this kind ... today in Nature . , The study, led by ... Matt Hurles from the Wellcome Trust Sanger Institute, looked at ... child,s entire genome looking for types of mutation known as ...
(Date:12/6/2009)... the Medical College of Wisconsin, in Milwaukee, found a ... sickle cell disease complications in children. Barriers to its ... were also identified. The study led by Amanda ... the Medical College and Children,s Research Institute at the ... American Society of Hematology meeting Dec. 7, 2009, in ...
(Date:12/6/2009)... -- Blood clotting, or coagulation, is an important ... vessel is injured. Sometimes, however, clots form on ... or do not dissolve naturally, a potentially life-threatening ... 51st Annual Meeting of the American Society of ... anticoagulants aspirin and heparin with the hope of ...
(Date:12/6/2009)... community, in cooperation with the Greater VA Healthcare System in West ... attendance is expected to soar to more than 5,000 veterans, active ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of the ... Los Angeles, will once again create a holiday party. This year,s ...
Breaking Medicine News(10 mins):Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 2Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 3Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 4Health News:Pharmacyclics, Inc. Reports Interim Safety and Clinical Data from a Phase I/II Clinical Trial of its Oral HDAC Inhibitor PCI-24781 in Lymphoma at the American Society of Hematology Annual Meeting 5Health News:Genetic studies reveal new causes of severe obesity in childhood 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 2Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 3Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 4Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 5Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 6Health News:Three Anticoagulant Studies May Change Current Medical Practice Including New Data Revealing That Preventative Use of Aspirin and Heparin is Not Effective in Reducing Recurrent, Unexplained Miscarriages 7Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3
... to 3200 deaths from heart attacks and stroke every year, ... Health . ,Value Added Tax (VAT), charged at 17.5%, ... most drinks. ,The authors assessed economic data on ... to calculate the likely impact of price rises on demand ...
... According to a new Brandeis University study published in ... Medicine,Health plans seldom require screening for substance abuse ... can improve detection. , This may be ... or substance abuse problems, only a fraction of whom ...
... help dialysis patients ,One of the most ... live a better quality life, dialysis-dependent patients, needs to ... a very significant part of the dialysis process. ... of red blood cells in bone marrow is the ...
... turn out economical if they are run on a massive ... team of researchers. They examined the large prevention programs underway ... They not only saw the unit cost of the program ... was much enhanced. ,With the recent report from the ...
... of its reaction to a particular variety of sugar present ... Biology textbooks neutrophils are regarded as mindless killers. White blood ... the policeman guarding our internal body. They protect our body ... by spotting and wiping out any intruder that invades the ...
... understanding the mechanisms underlying embryo development has taken ... biologists specialized in the study of the ... the design of mathematical models that simulate the ... study of wing formation in Drosophila, led by ...
Other Medicine News:Health News:Fat Tax Could Avoid Considerable Amount of Heart Attack and Stroke Deaths Annually 2Health News:Screening for Behavioral Health 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 2Health News:Analysis of Hemoglobin Level Control in Dialysis Patients 3Health News:HIV Prevention Programs on a Massive Scale Turn Out Economical 2Health News:WBC Selective About Sugar 2Health News:Understanding the Mechanism Underlying Embryo Development 2Health News:Understanding the Mechanism Underlying Embryo Development 3
(Date:12/4/2009)... Inc. (NYSE Amex: PIP ), a biodefense company ... today the presentation of new data from the Company,s ... Antigen (rPA) based anthrax vaccine is structurally stable and ... and including 55 degrees C. The data were ...
(Date:12/4/2009)... 4 Hospira, Inc. (NYSE: HSP ), ... today announced the launch of its next-generation 50 mL ... and solutions, and now offers a complete size range ... responsible VisIV product. The launch of the 50 mL ...
(Date:12/4/2009)... PharmAthene, Inc. (NYSE Amex: PIP ), ... and chemical threats, announced today that the Company ... effectiveness of Valortim® in an inhalation anthrax model ... The data are being presented during an oral ...
Breaking Medicine Technology:PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6AMICAS PACS For Mammography at RSNA 2009 61273 1AMICAS PACS For Mammography at RSNA 2009 61273 2AMICAS PACS For Mammography at RSNA 2009 61273 3Reportlinker Adds Diclofenac sodium 28CAS 15307 79 6 29 Market Research Report 2009 14821 1Reportlinker Adds Diclofenac sodium 28CAS 15307 79 6 29 Market Research Report 2009 14821 2Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 1Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 2Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 3Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 4Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 5Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 6Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 7Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 8Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 9Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 10Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 11Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 12Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 13Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 14Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 15Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 16Reportlinker Adds US Orthopedic Devices Market Analysis 26amp 3B Forecasts to 2015 6234 17
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: